Answers are grounded in this paper and cite their sources.
Little empirical research has compared the manufacturing strategies of corporate and independent new ventures. This study explores these differences with data from the young, science-based biotechnology industry, and examines the performance effects of manufacturing strategy variables including scope, competitive thrust, and capabilities. The results show that the corporate and independent biotechnology new ventures pursue significantly different manufacturing strategies, and that different dimensions of manufacturing strategies affect the performance of corporate vs. independent ventures quite differently.
No takes yet. Share an insight, caveat, or question.
Zahra et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: